Posts by Joseph Biederman, MD
-
Most Adults with ADHD Don't Renew Stimulant Prescriptions on a Timely Basis
Roy H. Perlis, MD, MSc, and Joseph Biederman, MD, of the Department of Psychiatry, provide real-world evidence of low rates of renewal of initial stimulant prescriptions by adults with attention-deficit/hyperactivity disorder, especially in primary care settings.
-
White Matter Abnormality Underlies Emotional Dysregulation in Children
Weakened microstructure along the cingulum–callosal neurocircuitry in white matter may represent a biomarker that identifies children at risk of developing mood disorders.
-
Autistic Traits in Children with ADHD Linked to High Risk of Psychopathology, Impaired Functioning
Youth with ADHD who have autistic traits are at high risk of developing psychiatric disorders and impaired psychosocial, academic and neurocognitive functioning within a decade.
-
ADHD May Be a Risk Factor for Sport-related Concussion in Teens and Young Adults
Attention-deficit/hyperactivity disorder is overrepresented among student athletes who have sustained a concussion and appears to complicate the course of recovery.
-
Exposure to Maternal Substance Use Disorder Increases Risk of Alcohol Use Disorder in Young Adults
In the largest study of its kind, psychiatrists at Massachusetts General Hospital have presented evidence that, independent of ADHD status, young adults who lived with a mother who had a substance use disorder are at increased risk of developing the disorder themselves.
-
Concurrent Use of Naltrexone May Mitigate Abuse Potential of Stimulants
Stimulants, the mainstay of ADHD treatment, are often abused because of the “high” they produce. Can the addition of naltrexone block that effect?
Biography
Joseph Biederman, MD, is chief of the Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD, director of the Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorders and professor of psychiatry at Harvard Medical School. Dr. Biederman is board certified in general and child psychiatry.
Dr. Biederman has been a mentor to more than 15 junior investigators in the field. He is on the editorial board of multiple journals, a reviewer for many psychiatric journals and has served as a grant reviewer in the Child Psychopathology and Treatment Review Committee of the NIMH. Dr. Biederman is the author and co-author over 800 scientific articles, 650 scientific abstracts and 70 book chapters.
In October 2007, Dr. Biederman was ranked as the second highest producer of high-impact papers in psychiatry overall throughout the world by the Institute for Scientific Information (ISI). The same organization ranked Dr. Biederman at #1 in terms of total citations to his papers published on ADD/ADHD in the past decade. In 2014, Thompson Reuters named Dr. Biederman to their list of the World’s Most Influential Scientific Minds, as ranking in the top 1% by citations for the field of psychiatry. Dr. Biederman's work is supported by multiple federal and pharmaceutical industry grants.
